Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- Open
- $528.99
- 52-wk high
- $615.00
- High
- $542.78
- 52-wk low
- $393.61
- Low
- $527.46
- Prev close
- $524.37
Smart money
Earnings
Earnings came in 22.0% above what analysts expected.
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $287.3M | $321.1M | $311.3M | $364.3M |
| Cost of what it sold | $18.1M | $24.4M | $26.8M | $40.0M |
| Gross profit | $269.1M | $296.6M | $284.5M | $324.2M |
| What it spent | ||||
| Research and development | $174.0M | $116.3M | $108.7M | $91.2M |
| Sales and admin | $209.1M | $209.1M | $268.5M | $289.4M |
| Other operating costs | — | $30.9M | — | — |
| Total operating expenses | $383.1M | $356.2M | $377.2M | $380.6M |
| What was left | ||||
| Operating profit | -$114.0M | -$59.6M | -$92.7M | -$56.3M |
| Interest on debt | $7.5M | $8.3M | $7.8M | -$7.9M |
| Profit before tax | -$114.2M | -$58.6M | -$94.4M | -$57.9M |
| Net profit | -$114.2M | -$58.6M | -$94.4M | -$57.9M |
| EBITDA | -$106.4M | -$49.9M | -$86.2M | -$56.3M |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
News
What the news says
Coverage is bullish
Tone of tracked coverage
Madrigal Pharmaceuticals (MDGL) Stock May Look Cheap On Sales But Risky On Cash Flow
NeutralAug 19Madrigal (NASDAQ: MDGL) awards Reed 647 RSUs and options on 1,078 shares
NeutralAug 192,410 Shares in Madrigal Pharmaceuticals, Inc. $MDGL Acquired by State of Wyoming
Leans bullishAug 16